Kenji Kabashima

机构：Agency for Science, Technology and Research, National Skin Centre, Kyoto University, Singapore Immunology Network · ORCID：0000-0002-0773-0554

发表论文 1208 篇 · 总被引 38395 次 · h-index 97

代表论文

• Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis Treatment (2026 · American Journal of Clinical Dermatology · 被引 2)
• IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis (2026 · Journal of Allergy and Clinical Immunology · 被引 2)
• Bullous Rheumatoid Neutrophilic Dermatitis in a Juvenile Idiopathic Arthritis Patient Treated With Tocilizumab (2026 · International Journal of Dermatology · 被引 1)
• Mouse ICSI impairs fertility of male offspring by disruption of fetomaternal tolerance (2026 · Development · 被引 1)
• Sustained On- and Off-Treatment Disease Control in Patients With Moderate-to-Severe Atopic Dermatitis Following 12-Week, Open-Label, Once-Daily Abrocitinib 200 mg: A Post Hoc Analysis of the Phase 3 JADE REGIMEN Study (2026 · SKIN The Journal of Cutaneous Medicine · 被引 1)
• Response to letter to the editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis (2026 · Journal of Dermatological Treatment)